Pacira BioSciences' Other Working Capital Changes fell 19393.52% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 6608.83%. This contributed to the annual value of $7.4 million for FY2024, which is 2364.35% down from last year.
As of Q3 2025, Pacira BioSciences' Other Working Capital Changes stood at -$4.7 million, which was down 19393.52% from $11.5 million recorded in Q2 2025.
Pacira BioSciences' 5-year Other Working Capital Changes high stood at $11.5 million for Q2 2025, and its period low was -$4.7 million during Q3 2025.
Over the past 5 years, Pacira BioSciences' median Other Working Capital Changes value was $2.1 million (recorded in 2022), while the average stood at $1.7 million.
Over the last 5 years, Pacira BioSciences' Other Working Capital Changes had its largest YoY gain of 177716.54% in 2022, and its largest YoY loss of 676250.0% in 2022.
Pacira BioSciences' Other Working Capital Changes (Quarter) stood at -$3.8 million in 2021, then surged by 156.33% to $2.1 million in 2022, then grew by 24.5% to $2.7 million in 2023, then tumbled by 61.48% to $1.0 million in 2024, then crashed by 562.23% to -$4.7 million in 2025.
Its last three reported values are -$4.7 million in Q3 2025, $11.5 million for Q2 2025, and $7.1 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value